DPHARMA
Quarterly rpt on consolidated results for the financial period ended 30 Sep 2022
| DUOPHARMA BIOTECH BERHAD |
| Financial Year End | 31 Dec 2022 |
| Quarter | 3 Qtr |
| Quarterly report for the financial period ended | 30 Sep 2022 |
| The figures | have not been audited |
- Default Currency
- Other Currency
Currency: Malaysian Ringgit (MYR)
SUMMARY OF KEY FINANCIAL INFORMATION
|
INDIVIDUAL PERIOD
|
CUMULATIVE PERIOD
|
||||
CURRENT YEAR QUARTER
|
PRECEDING YEAR CORRESPONDING QUARTER |
CURRENT YEAR TO DATE
|
PRECEDING YEAR CORRESPONDING PERIOD |
||
|
30 Sep 2022
|
30 Sep 2021
|
30 Sep 2022
|
30 Sep 2021
|
||
|
$$'000
|
$$'000
|
$$'000
|
$$'000
|
||
| 1 | Revenue |
177,074
|
171,838
|
544,757
|
493,731
|
| 2 | Profit/(loss) before tax |
21,385
|
22,483
|
69,504
|
65,856
|
| 3 | Profit/(loss) for the period |
16,349
|
16,963
|
52,951
|
49,967
|
| 4 | Profit/(loss) attributable to ordinary equity holders of the parent |
16,349
|
16,963
|
52,951
|
49,967
|
| 5 | Basic earnings/(loss) per share (Subunit) |
1.72
|
1.80
|
5.59
|
5.31
|
| 6 | Proposed/Declared dividend per share (Subunit) |
0.00
|
0.00
|
0.50
|
0.50
|
AS AT END OF CURRENT QUARTER
|
AS AT PRECEDING FINANCIAL YEAR END
|
||||
| 7 |
Net assets per share attributable to ordinary equity holders of the parent ($$) |
0.6800
|
0.6600
|
||
Definition of Subunit:
In a currency system, there is usually a main unit (base) and
subunit that is a fraction amount of the main unit.
Example for the subunit as follows:
| Country | Base Unit | Subunit |
| Malaysia | Ringgit | Sen |
| United States | Dollar | Cent |
| United Kingdom | Pound | Pence |
Announcement Info
| Company Name | DUOPHARMA BIOTECH BERHAD |
| Stock Name | DPHARMA |
| Date Announced | 09 Nov 2022 |
| Category | Financial Results |
| Reference Number | FRA-08112022-00004 |